EYEQ FORMULATION
LIVE
Serial Number
99020672
Owner
Orasis Pharmaceuticals Ltd.Attorney
B. Brett HeavnerFiling Date
Jan 28, 2025
EYEQ FORMULATION Trademark
Serial Number: 99020672
EYEQ FORMULATION is a trademark filed by
Orasis Pharmaceuticals Ltd.
on January 28, 2025. The trademark is classified under Class 5 (Pharmaceuticals).
The application is currently pending registration.
Trademark Classes
Owner Contact Info
Legal Representation
Attorney of Record
B. Brett HeavnerCorrespondence Address
B. Brett Heavner Finnegan Henderson Farabow Garrett & Dunner LLP
901 New York Avenue NW
Washington, DC 20001
United States
Trademark Details
Filing Date
January 28, 2025
Registration Date
Not Registered
Published for Opposition
August 19, 2025
Goods & Services
Pharmaceutical preparations for the treatment of eye disorders and diseases
Filing History
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 14, 2026 EXRA
TEAS STATEMENT OF USE RECEIVED
Apr 14, 2026 EISU
SOU EXTENSION 1 GRANTED
Apr 14, 2026 EX1G
SOU EXTENSION 1 FILED
Apr 14, 2026 EXT1
SOU TEAS EXTENSION RECEIVED
Apr 14, 2026 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Oct 14, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 19, 2025 NPUB
PUBLISHED FOR OPPOSITION
Aug 19, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 13, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 11, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
Jul 11, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jul 11, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Jul 11, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jul 11, 2025 CNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 8, 2025 GNRN
NON-FINAL ACTION E-MAILED
Jul 8, 2025 GNRT
NON-FINAL ACTION WRITTEN
Jul 8, 2025 CNRT
ASSIGNED TO EXAMINER
Jul 8, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 28, 2025 NWOS
APPLICATION FILING RECEIPT MAILED
Jan 28, 2025 MAFR
NEW APPLICATION ENTERED
Jan 28, 2025 NWAP